Zamorano JCA, Chirino-Barceló YA

Language: Spanish
References: 14
Page: 162-166
PDF size: 224.05 Kb.

ABSTRACT

The first hospital works in colonial times were directed by friars, at this time the child was considered a "small adult". During Independence and immediately after it, there is a lag in care for this age group, but finally, in the 20th century, the National Pediatric movement began; hospitals exclusively for children arose during this period, followed by the creation of modern Institutes dedicated to the care of Mexican children. The development of diagnostic and therapeutic clinical trials and systematic reviews constitute an important advance in the practice of science, although in the pediatric age they are less frequent; likely due to the high biological variability of the pediatric population; from conception, intrauterine growth and birth, children present rapid and complex processes of growth and maturation. Another challenge is the ethical aspects in pediatric clinical research, so we address two important concepts such as assent and informed consent. We will analyze the Mexican Regulation for Research on Children, through the Regulation of the General Health Law on Research for Health, which regulates how research should be carried out in public or private institutions in the country. As teachers, it is important to create a mind that involves the complexity between pediatric practice, teaching and research, considering these three elements as the axis in medical education.

REFERENCES

1. Prado-Vértiz A. Pasado y presente de la pediatría mexicana. Gac Med Mex. 1968; 98 (4): 469-483.

2. Santos-Preciado JI. El Hospital Infantil de México y su Boletín Médico: un hito en la historia de la pediatría mexicana. Bol Med Hosp Infant Mex. 2008; 65 (2): 81-82.

3. Martorell R. Improved nutrition in the first 1000 days and adult human capital and health. Am J Hum Biol. 2017; 29 (2): 10.1002/ajhb.22952. doi: 10.1002/ajhb.22952.

4. Martinez-Castaldi C, Silverstein M, Bauchner H. Child versus adult research: the gap in high-quality study design. Pediatrics. 2008; 122 (1): 52-57. doi: 10.1542/peds.2007-2849.

5. Moya M. La investigación en pediatría al día de hoy. An Pediatr (Barc). 2014; 81 (2): 67-68.

6. Gordon B. Investigación que involucre a niños. Disponible en: https://bioethics.miami.edu/_assets/pdf/international/pan-american-bioethics-initiative/pabi-fogarty-grant/mexico/Modules/module14881.pdf

7. Sáenz Cortés M, Escobar López MT, Aristizabal Tobler CC. Los menores y adolescentes en la investigación clínica. Tensiones y aspectos éticos. Escritos. 2016; 24 (53): 345-367. Disponible en: https://doi.org/10.18566/escr.v24n53.a06

8. Saldaña M. Las peculiaridades del niño y lo fármacos: farmacocinética, farmacodinámica y desarrollo. Investigación pediátrica clínica y trasnacional en el área genómica. Madrid: Instituto Roche; 2012; pp. 19-26.

9. Latasch L, Freye E. Pain and opioids in preterm and newborns. Anaesthesist. 2002; 51 (4): 272-284.

10. Calvo Malvar M, Benítez Estévez AJ. Papel de los modelos farmacocinéticos de población. Revisión de métodos. Química Clínica. 2004; 23 (6): 417-422.

11. Thomson AH, Jacqz-Aigrain E, Choonara I. Population pharmacokinetics and pharmacodynamics. In: Jacqz-Aigrain E, Choonara I, eds. Paediatric clinical pharmacology. London: Taylor and Francis Group; 2006.

12. Muro M. Ensayos clínicos en niños. Nuevo Real Decreto, viejos conceptos. An Pediatr (Barc). 2004; 61: 387-389.

13. Aripin KN, Choonara I, Sammons HM. A systematic review of paediatric randomised controlled drug trials published in 2007. Arch Dis Child. 2010; 95 (6): 469-473. doi: 10.1136/adc.2009.173591.

14. Larios-Farak TC, Rendón-García H, Ornelas-Ceballos JR, Covarrubias-Espinoza G, Ríos-García CG, Morales-Peralta A. Supervivencia de niños con leucemia linfoblástica aguda de riesgo intermedio. Bol Clin Hosp Infant Edo Son. 2016; 33 (1): 19-25.